Speaker Profile

Ph.D., Research Scientist, Stanford

Dr. Liang is passionate about developing diagnostic and therapeutic solutions for pregnancy complications. She is the first inventor of five patents in the maternal health space developed at Stanford University. She globally characterized thousands of molecular features from small amounts of blood and urine samples from pregnant women, and developed tests based on only a few biomarkers from a mother’s blood or urine using machine learning. Her work has been published in Cell, and she co-authored over a dozen publications. She is also a Co-Awardee in Maternal, Neonatal, and Child Health from the Gates Foundation. Beyond developing tests for pregnancy, Dr. Liang has focused on drug development for pregnancy and identified novel therapeutic candidates for preterm birth, a significant unmet need. She is the Founder and CEO of 9 MONTHS, leading its efforts to develop first-in-class solutions for pregnancy complications globally. With personal experience of preterm labor, Dr. Liang’s mission is to improve maternal and child health by reducing pregnancy complications. She received postdoctoral training at Stanford University, holds degrees from Tsinghua University (Chemistry and Biology) and Stowers Institute for Medical Research, and is also a graduate of the Ignite program at the Graduate School of Business of Stanford University.

Beyond Prediction: Developing Therapeutic Solutions for Preterm Birth
10% of babies are born preterm worldwide (15 million/yr). However, there is no effective medicine to prevent or treat preterm birth and other pregnancy complications. We aim to provide first-in-class solutions for complications in pregnancy, including preterm birth, developing new medication of high efficacy and great safety profiles in pregnancy.

 Session Abstract – PMWC 2022 Silicon Valley